Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and dexmedetomidine for liver protection after cardiopulmonary bypass cardiac surgery
ChiCTR2500106421Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ascorbic acid and dexmedetomidine in cardiac disease, Postoperative liver injury (POLI), inflammation and 1 more (4 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Liver function indicators (AST, ALT, direct bilirubin, total bilirubin) and Incidence of liver function injury. Started Jul 2025; status: completed.
02
Drugs
ascorbic aciddexmedetomidine
03
Conditions
cardiac diseasePostoperative liver injury (POLI)inflammation
Beyond the preview
Go deeper on ChiCTR2500106421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106421.